These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20394571)

  • 1. Safety considerations of the use of second generation antipsychotics in the treatment of major depression: extrapyramidal and metabolic side effects.
    DeBattista C; DeBattista K
    Curr Drug Saf; 2010 Jul; 5(3):263-6. PubMed ID: 20394571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotics as antidepressants.
    Roberts RJ; Lohano KK; El-Mallakh RS
    Asia Pac Psychiatry; 2016 Sep; 8(3):179-88. PubMed ID: 25963405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
    Conley RR; Kelly DL
    Isr J Psychiatry Relat Sci; 2005; 42(1):51-60. PubMed ID: 16134407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Effects of Second-Generation Antipsychotics as Adjuncts to Antidepressants: Are the Risks Worth the Benefits?
    Thase ME
    Psychiatr Clin North Am; 2016 Sep; 39(3):477-86. PubMed ID: 27514300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of bipolar depression: an update.
    Thase ME
    Curr Psychiatry Rep; 2006 Dec; 8(6):478-88. PubMed ID: 17094928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activating and Sedating Properties of Medications Used for the Treatment of Major Depressive Disorder and Their Effect on Patient Functioning.
    Citrome LL; McIntyre RS; Manning JS; McIntosh D
    J Clin Psychiatry; 2019 Apr; 80(3):. PubMed ID: 31090280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation antipsychotics for major depressive disorder and dysthymia.
    Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quetiapine XR efficacy and tolerability as monotherapy and as adjunctive treatment to conventional antidepressants in the acute and maintenance treatment of major depressive disorder: a review of registration trials.
    McIntyre RS; Muzina DJ; Adams A; Lourenco MT; Law CW; Soczynska JK; Woldeyohannes HO; Nathanson J; Kennedy SH
    Expert Opin Pharmacother; 2009 Dec; 10(18):3061-75. PubMed ID: 19954275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapyramidal adverse events associated with atypical antipsychotic treatment of bipolar disorder.
    Gentile S
    J Clin Psychopharmacol; 2007 Feb; 27(1):35-45. PubMed ID: 17224710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical antipsychotics in bipolar disorder: systematic review of randomised trials.
    Derry S; Moore RA
    BMC Psychiatry; 2007 Aug; 7():40. PubMed ID: 17705840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics.
    Spina E; de Leon J
    Expert Opin Drug Metab Toxicol; 2014 May; 10(5):721-46. PubMed ID: 24494611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
    Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
    Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder.
    Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G
    Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treating depression with adjunctive antipsychotics.
    Mulder R; Hamilton A; Irwin L; Boyce P; Morris G; Porter RJ; Malhi GS
    Bipolar Disord; 2018 Nov; 20 Suppl 2():17-24. PubMed ID: 30328223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of adjunctive antipsychotics to treat depression in UK primary care.
    Lamy FX; Saragoussi D; Johnson ME; Guiraud-Diawara A; Jørgensen KT; Loze JY; Maguire A
    Curr Med Res Opin; 2017 May; 33(5):891-898. PubMed ID: 28277876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics in the treatment of schizophrenia: an overview.
    Tandon R
    J Clin Psychiatry; 2011; 72 Suppl 1():4-8. PubMed ID: 22217436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bipolar depression: Managing patients with second generation antipsychotics.
    Avery LM; Drayton SJ
    Int J Psychiatry Med; 2016; 51(2):145-59. PubMed ID: 27079776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.